Abstract
Background/aims: The soluble interleukin-2 receptor is a useful, non-specific marker of in-vivo activated cellular immune functions. The aim of this study was to evaluate the correlation between this marker and clinical evolution of ulcerative colitis. Methods: Serum soluble interleukin-2 receptor levels were determined, by an enzyme immune assay, in 105 patients affected by ulcerative colitis with different extent and activity of disease. Forty-six of these patients were restaged in a follow-up study, and their serum-soluble interleukin-2 receptor concentrations were measured again. Results: Serum soluble interleukin-2 receptor level is higher in pan-ulcerative colitis than in left ulcerative colitis (P = 0.050) and much higher in active than in quiescent stage of disease (P = 0.029). Clinical relapse of disease is accompanied by a serum soluble interleukin-2 receptor rise (P = 0.0697), whereas clinical and histological improvement in disease is accompanied by its significant decrease (P = 0.0009). Conclusion: In ulcerative colitis the serum determination of soluble interleukin-2 receptor is a useful and non-invasive marker of activity, and also extension and evolution of the disease.
| Original language | English |
|---|---|
| Pages (from-to) | 173-177 |
| Number of pages | 5 |
| Journal | European Journal of Gastroenterology and Hepatology |
| Volume | 9 |
| Issue number | 2 |
| Publication status | Published - 1997 |
Fingerprint
Keywords
- Soluble interleukin-2 receptor
- Ulcerative colitis
ASJC Scopus subject areas
- Gastroenterology
Cite this
The soluble inteuleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis. / Balzano, Antonio; Bove, Antonio; Leonardi, Enrico; Bevilacqua, Nazario; Grande, Giovanni; Ascierto, Paolo A.; Castello, Giuseppe.
In: European Journal of Gastroenterology and Hepatology, Vol. 9, No. 2, 1997, p. 173-177.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The soluble inteuleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis
AU - Balzano, Antonio
AU - Bove, Antonio
AU - Leonardi, Enrico
AU - Bevilacqua, Nazario
AU - Grande, Giovanni
AU - Ascierto, Paolo A.
AU - Castello, Giuseppe
PY - 1997
Y1 - 1997
N2 - Background/aims: The soluble interleukin-2 receptor is a useful, non-specific marker of in-vivo activated cellular immune functions. The aim of this study was to evaluate the correlation between this marker and clinical evolution of ulcerative colitis. Methods: Serum soluble interleukin-2 receptor levels were determined, by an enzyme immune assay, in 105 patients affected by ulcerative colitis with different extent and activity of disease. Forty-six of these patients were restaged in a follow-up study, and their serum-soluble interleukin-2 receptor concentrations were measured again. Results: Serum soluble interleukin-2 receptor level is higher in pan-ulcerative colitis than in left ulcerative colitis (P = 0.050) and much higher in active than in quiescent stage of disease (P = 0.029). Clinical relapse of disease is accompanied by a serum soluble interleukin-2 receptor rise (P = 0.0697), whereas clinical and histological improvement in disease is accompanied by its significant decrease (P = 0.0009). Conclusion: In ulcerative colitis the serum determination of soluble interleukin-2 receptor is a useful and non-invasive marker of activity, and also extension and evolution of the disease.
AB - Background/aims: The soluble interleukin-2 receptor is a useful, non-specific marker of in-vivo activated cellular immune functions. The aim of this study was to evaluate the correlation between this marker and clinical evolution of ulcerative colitis. Methods: Serum soluble interleukin-2 receptor levels were determined, by an enzyme immune assay, in 105 patients affected by ulcerative colitis with different extent and activity of disease. Forty-six of these patients were restaged in a follow-up study, and their serum-soluble interleukin-2 receptor concentrations were measured again. Results: Serum soluble interleukin-2 receptor level is higher in pan-ulcerative colitis than in left ulcerative colitis (P = 0.050) and much higher in active than in quiescent stage of disease (P = 0.029). Clinical relapse of disease is accompanied by a serum soluble interleukin-2 receptor rise (P = 0.0697), whereas clinical and histological improvement in disease is accompanied by its significant decrease (P = 0.0009). Conclusion: In ulcerative colitis the serum determination of soluble interleukin-2 receptor is a useful and non-invasive marker of activity, and also extension and evolution of the disease.
KW - Soluble interleukin-2 receptor
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=0030614996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030614996&partnerID=8YFLogxK
M3 - Article
VL - 9
SP - 173
EP - 177
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
SN - 0954-691X
IS - 2
ER -